We are delighted to be at the World Evidence, Pricing and Access Congress (World EPA) as Platinum sponsors. World EPA is Europe’s largest congress in market access, pricing and evidence with over 300 speakers, multiple streams and over 1,000 attendees. As a world-leading forum, World EPA provides the opportunity to showcase solutions and thought leadership within market access and pricing to key stakeholders across the pharmaceutical and biotechnology industry.
Over 3 days, the congress will cover topics that are core to market access and pricing, including RWE, HTA, medical devices, affordability, digital health analytics and emerging markets.
Want to learn more about how our team can help you achieve your market access goals? Come and meet our experts at booth 3 in Amsterdam.
With a background leading commercial teams in pharma services, Andrew started Bioscript in 2005 and has overseen the growth of the company across medical communications, regulatory writing, HEOR, and market access.
James has over 25 years of experience in the healthcare industry and consulting, with extensive experience in HTA optimisation, evaluation of strategic pricing and market access implications for new launches and product/portfolio lifecycle optimisation.
Catherine has worked within market access for more than 14 years, with valuable experience ranging from market access strategy to evidence generation recommendations and has a particular interest in patient engagement and advocacy.
Francesca has broad market access experience at global and local levels, with a specialty in the development of value propositions and supporting materials (e.g., GVDs and economic models), gained by working directly with stakeholders.
Paula has a wealth of experience in developing key value messages from scientific literature to produce story flows tailored to different audiences and convey messages effectively.
Alba has wide-ranging expertise within market access and pricing, with a specific speciality in developing valuable tools ranging from reimbursement trackers to tendering deal calculators in order to support market access activities.
Tobias takes a consultative approach to building long-term partnerships with those within the pharmaceutical sector. His motto, “who knows where an interesting conversation might lead..."
Valid Insight can support you in achieving your goal of optimal patient access
As part of Bioscript Group, we are experts in understanding the global payer environment and can help you overcome evolving market access strategy and communication challenges across critical points in the product lifecycle.
Connect with us today and discover how our specialists can help.
